Table 3.
Fall and non-fall participant characteristics (percentages or means (SD)). The Tromsø Study 2001-2002
| Fall participants | Non-fall participants | p-value1 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variabel (n) | All (N = 803) | Women (n = 442) | Men (n = 361) | All (N = 1638) | Women (n = 879) | Men (n = 759) | All | Women | Men |
| Mean age, years | 72.2 (4.9) | 72.3 (4.9) | 72.1 (4.9) | 72.0 (4.8) | 72.2 (4.8) | 71.6 (4.8) | 0.219 | 0.706 | 0.172 |
| Mean hemoglobin, g/dl | 13.8 (1.1) | 13.4 (0.9) | 14.4 (1.1) | 13.9 (1.1) | 13.4 (1.0) | 14.4 (1.1) | 0.550 | 0.373 | 0.739 |
| Anemiaa, % | 7.9 | 7.0 | 8.9 | 7.6 | 6.1 | 9.4 | 0.852 | 0.543 | 0.791 |
| Mulitimorbidityb, % | 4.2 | 4.6 | 3.4 | 4.0 | 3.2 | 4.8 | 0.849 | 0.332 | 0.530 |
| Disabilityc, % | 28.0 | 32.0 | 23.2 | 25.6 | 31.0 | 19.0 | 0.361 | 0.795 | 0.239 |
| Frailtyd, % | 41.3 | 43.6 | 38.5 | 38.1 | 48.4 | 27.8 | 0.450 | 0.421 | 0.064 |
| Hypertensione, % | 63.3 | 64.7 | 61.5 | 66.2 | 68.9 | 63.0 | 0.150 | 0.121 | 0.613 |
| Use of antihypertensives, % | 33.2 | 33.7 | 32.5 | 30.5 | 30.0 | 31.0 | 0.187 | 1.277 | 0.633 |
| Use of ≥ 5 drugsf, % | 18.1 | 16.1 | 20.6 | 14.9 | 14.5 | 15.3 | 0.077 | 0.483 | 0.063 |
| Low physical activity level, % | 6.5 | 8.4 | 4.5 | 9.3 | 11.6 | 6.9 | 0.029 | 0.096 | 0.126 |
| Body mass index, kg/m2 | 26.8 (4.2) | 27.2 (4.6) | 26.3 (3.5) | 26.7 (4.1) | 26.9 (4.5) | 26.4 (3.5) | 0.471 | 0.213 | 0.574 |
1P-value for difference between fall and non-fall participants (two-sided t-test for comparisons of means for continuous variables and Chi-square test for categorical variables)
aWHO criteria (< 12 g/dl in women, < 13 g/dl in men)
bSelf-reported ≥ 2 of the following diseases: asthma/emphysema/chronic bronchitis, cancer (ever), diabetes, stroke, coronary heart disease, peptic ulcer
cSelf-reported functional status
dModified Fried’s criteria
eBlood pressure > 140/90 mmHg
fSelf-reported drugs used on a regular basis